{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T07:14:10Z","timestamp":1781766850656,"version":"3.54.5"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20220671, BK20210910, BK20201012, and BK20210913"],"award-info":[{"award-number":["BK20220671, BK20210910, BK20201012, and BK20210913"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National science research in Universities of Jiangsu Province","award":["22KJB320009, 21KJA320008 and 21KJB320021"],"award-info":[{"award-number":["22KJB320009, 21KJA320008 and 21KJB320021"]}]},{"name":"Outstanding Talents Research Startup Fund of Xuzhou Medical University","award":["D2021049"],"award-info":[{"award-number":["D2021049"]}]},{"name":"Jiangsu Provincial Young Science and Technology Talent Lifting Program","award":["JSTJ-2025-496"],"award-info":[{"award-number":["JSTJ-2025-496"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82471378, 82304535, 81972719, 82273207, and 82003164"],"award-info":[{"award-number":["82471378, 82304535, 81972719, 82273207, and 82003164"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"DOI":"10.1186\/s13058-025-02193-5","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T22:05:55Z","timestamp":1765577155000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Nuclear PD-L1 drives IFN-\u03b3-promoted lung metastasis of triple-negative breast cancer via POLR2A-mediated transcriptional activation of LY6E"],"prefix":"10.1186","volume":"28","author":[{"given":"Xu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunshun","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianzheng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangchun","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junnian","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9263-6468","authenticated-orcid":false,"given":"Ming","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,12]]},"reference":[{"issue":"1","key":"2193_CR1","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s13045-022-01341-0","volume":"15","author":"Y Li","year":"2022","unstructured":"Li Y, Zhang H, Merkher Y, Chen L, Liu N, Leonov S, Chen Y. Recent advances in therapeutic strategies for triple-negative breast cancer. J Hematol Oncol. 2022;15(1):121.","journal-title":"J Hematol Oncol"},{"issue":"7","key":"2193_CR2","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1007\/s00432-018-2644-2","volume":"144","author":"A Ignatov","year":"2018","unstructured":"Ignatov A, Eggemann H, Burger E, Ignatov T. Patterns of breast cancer relapse in accordance to biological subtype. J Cancer Res Clin Oncol. 2018;144(7):1347\u201355.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"2193_CR3","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1001\/jamaoncol.2018.4224","volume":"5","author":"LA Emens","year":"2019","unstructured":"Emens LA, Cruz C, Eder JP, Braiteh F, Chung C, Tolaney SM, Kuter I, Nanda R, Cassier PA, Delord JP, et al. Long-term clinical outcomes and biomarker analyses of atezolizumab therapy for patients with metastatic triple-negative breast cancer: A phase 1 study. JAMA Oncol. 2019;5(1):74\u201382.","journal-title":"JAMA Oncol"},{"issue":"3","key":"2193_CR4","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s00262-020-02736-z","volume":"70","author":"D Kwapisz","year":"2021","unstructured":"Kwapisz D. Pembrolizumab and Atezolizumab in triple-negative breast cancer. Cancer Immunol Immunother. 2021;70(3):607\u201317.","journal-title":"Cancer Immunol Immunother"},{"issue":"3","key":"2193_CR5","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s10549-017-4537-5","volume":"167","author":"LY Dirix","year":"2018","unstructured":"Dirix LY, Takacs I, Jerusalem G, Nikolinakos P, Arkenau HT, Forero-Torres A, Boccia R, Lippman ME, Somer R, Smakal M, et al. Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN solid tumor study. Breast Cancer Res Treat. 2018;167(3):671\u201386.","journal-title":"Breast Cancer Res Treat"},{"key":"2193_CR6","doi-asserted-by":"crossref","unstructured":"Tu E, McGlinchey K, Wang J, Martin P, Ching SL, Floc\u2019h N, Kurasawa J, Starrett JH, Lazdun Y, Wetzel L et al. Anti-PD-L1 and anti-CD73 combination therapy promotes T cell response to EGFR-mutated NSCLC. JCI Insight 2022;7(3).","DOI":"10.1172\/jci.insight.142843"},{"key":"2193_CR7","doi-asserted-by":"publisher","first-page":"118565","DOI":"10.1016\/j.lfs.2020.118565","volume":"262","author":"Y Ma","year":"2020","unstructured":"Ma Y, Han J, Jiang J, Zheng Z, Tan Y, Liu C, Zhao Y. Ultrasound targeting of microbubble-bound anti PD-L1 mAb to enhance anti-tumor effect of cisplatin in cervical cancer xenografts treatment. Life Sci. 2020;262:118565.","journal-title":"Life Sci"},{"key":"2193_CR8","doi-asserted-by":"publisher","first-page":"847","DOI":"10.3389\/fimmu.2018.00847","volume":"9","author":"F Castro","year":"2018","unstructured":"Castro F, Cardoso AP, Goncalves RM, Serre K, Oliveira MJ. Interferon-gamma at the crossroads of tumor immune surveillance or evasion. Front Immunol. 2018;9:847.","journal-title":"Front Immunol"},{"issue":"14","key":"2193_CR9","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.1158\/0008-5472.CAN-19-0596","volume":"79","author":"M Song","year":"2019","unstructured":"Song M, Ping Y, Zhang K, Yang L, Li F, Zhang C, Cheng S, Yue D, Maimela NR, Qu J, et al. Low-Dose IFNgamma induces tumor cell stemness in tumor microenvironment of Non-Small cell lung cancer. Cancer Res. 2019;79(14):3737\u201348.","journal-title":"Cancer Res"},{"issue":"5","key":"2193_CR10","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41556-020-0495-y","volume":"22","author":"S Singh","year":"2020","unstructured":"Singh S, Kumar S, Srivastava RK, Nandi A, Thacker G, Murali H, Kim S, Baldeon M, Tobias J, Blanco MA, et al. Loss of ELF5-FBXW7 stabilizes IFNGR1 to promote the growth and metastasis of triple-negative breast cancer through interferon-gamma signalling. Nat Cell Biol. 2020;22(5):591\u2013602.","journal-title":"Nat Cell Biol"},{"issue":"6","key":"2193_CR11","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.molcel.2019.04.005","volume":"74","author":"X Tu","year":"2019","unstructured":"Tu X, Qin B, Zhang Y, Zhang C, Kahila M, Nowsheen S, Yin P, Yuan J, Pei H, Li H, et al. PD-L1 (B7-H1) competes with the RNA exosome to regulate the DNA damage response and can be targeted to sensitize to radiation or chemotherapy. Mol Cell. 2019;74(6):1215\u201326.","journal-title":"Mol Cell"},{"issue":"7","key":"2193_CR12","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/s41422-020-0315-8","volume":"30","author":"J Yu","year":"2020","unstructured":"Yu J, Qin B, Moyer AM, Nowsheen S, Tu X, Dong H, Boughey JC, Goetz MP, Weinshilboum R, Lou Z, et al. Regulation of sister chromatid cohesion by nuclear PD-L1. Cell Res. 2020;30(7):590\u2013601.","journal-title":"Cell Res"},{"issue":"10","key":"2193_CR13","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1038\/s41556-020-0575-z","volume":"22","author":"J Hou","year":"2020","unstructured":"Hou J, Zhao R, Xia W, Chang CW, You Y, Hsu JM, Nie L, Chen Y, Wang YC, Liu C, et al. PD-L1-mediated gasdermin C expression switches apoptosis to pyroptosis in cancer cells and facilitates tumour necrosis. Nat Cell Biol. 2020;22(10):1264\u201375.","journal-title":"Nat Cell Biol"},{"issue":"9","key":"2193_CR14","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1038\/s41556-020-0562-4","volume":"22","author":"Y Gao","year":"2020","unstructured":"Gao Y, Nihira NT, Bu X, Chu C, Zhang J, Kolodziejczyk A, Fan Y, Chan NT, Ma L, Liu J, et al. Acetylation-dependent regulation of PD-L1 nuclear translocation dictates the efficacy of anti-PD-1 immunotherapy. Nat Cell Biol. 2020;22(9):1064\u201375.","journal-title":"Nat Cell Biol"},{"issue":"1","key":"2193_CR15","doi-asserted-by":"publisher","first-page":"6830","DOI":"10.1038\/s41467-024-51242-8","volume":"15","author":"Z Shu","year":"2024","unstructured":"Shu Z, Dwivedi B, Switchenko JM, Yu DS, Deng X. PD-L1 deglycosylation promotes its nuclear translocation and accelerates DNA double-strand-break repair in cancer. Nat Commun. 2024;15(1):6830.","journal-title":"Nat Commun"},{"issue":"3","key":"2193_CR16","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/s44319-024-00354-9","volume":"26","author":"NT Nihira","year":"2025","unstructured":"Nihira NT, Wu W, Hosoi M, Togashi Y, Sunada S, Miyoshi Y, Miki Y, Ohta T. Nuclear PD-L1 triggers tumour-associated inflammation upon DNA damage. EMBO Rep. 2025;26(3):635\u201355.","journal-title":"EMBO Rep"},{"issue":"4","key":"2193_CR17","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1038\/s41418-020-00651-5","volume":"28","author":"W Du","year":"2021","unstructured":"Du W, Zhu J, Zeng Y, Liu T, Zhang Y, Cai T, Fu Y, Zhang W, Zhang R, Liu Z, et al. KPNB1-mediated nuclear translocation of PD-L1 promotes non-small cell lung cancer cell proliferation via the Gas6\/MerTK signaling pathway. Cell Death Differ. 2021;28(4):1284\u2013300.","journal-title":"Cell Death Differ"},{"issue":"9","key":"2193_CR18","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/s41419-022-05217-6","volume":"13","author":"JJ Lee","year":"2022","unstructured":"Lee JJ, Kim SY, Kim SH, Choi S, Lee B, Shin JS. STING mediates nuclear PD-L1 targeting-induced senescence in cancer cells. Cell Death Dis. 2022;13(9):791.","journal-title":"Cell Death Dis"},{"key":"2193_CR19","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.canlet.2021.12.017","volume":"527","author":"R Ma","year":"2022","unstructured":"Ma R, Liu Y, Che X, Li C, Wen T, Hou K, Qu X. Nuclear PD-L1 promotes cell cycle progression of BRAF-mutated colorectal cancer by inhibiting THRAP3. Cancer Lett. 2022;527:127\u201339.","journal-title":"Cancer Lett"},{"issue":"7","key":"2193_CR20","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/s41419-020-2701-z","volume":"11","author":"W Yu","year":"2020","unstructured":"Yu W, Hua Y, Qiu H, Hao J, Zou K, Li Z, Hu S, Guo P, Chen M, Sui S, et al. PD-L1 promotes tumor growth and progression by activating WIP and beta-catenin signaling pathways and predicts poor prognosis in lung cancer. Cell Death Dis. 2020;11(7):506.","journal-title":"Cell Death Dis"},{"issue":"1","key":"2193_CR21","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41421-023-00521-7","volume":"9","author":"J Yu","year":"2023","unstructured":"Yu J, Zhuang A, Gu X, Hua Y, Yang L, Ge S, Ruan J, Chai P, Jia R, Fan X. Nuclear PD-L1 promotes EGR1-mediated angiogenesis and accelerates tumorigenesis. Cell Discov. 2023;9(1):33.","journal-title":"Cell Discov"},{"key":"2193_CR22","doi-asserted-by":"crossref","unstructured":"Liu Y, Yang Z, Wang S, Miao R, Chang CM, Zhang J, Zhang X, Hung MC, Hou J. Nuclear PD-L1 compartmentalization suppresses tumorigenesis and overcomes immunocheckpoint therapy resistance in mice via histone macroH2A1. J Clin Invest 2024;134(22).","DOI":"10.1172\/JCI181314"},{"key":"2193_CR23","doi-asserted-by":"publisher","first-page":"216964","DOI":"10.1016\/j.canlet.2024.216964","volume":"593","author":"Y Yu","year":"2024","unstructured":"Yu Y, Liang Y, Xie F, Zhang Z, Zhang P, Zhao X, Zhang Z, Liang Z, Li D, Wang L, et al. Tumor-associated macrophage enhances PD-L1-mediated immune escape of bladder cancer through PKM2 dimer-STAT3 complex nuclear translocation. Cancer Lett. 2024;593:216964.","journal-title":"Cancer Lett"},{"issue":"7050","key":"2193_CR24","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/nature03799","volume":"436","author":"AJ Minn","year":"2005","unstructured":"Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, Giri DD, Viale A, Olshen AB, Gerald WL, Massague J. Genes that mediate breast cancer metastasis to lung. Nature. 2005;436(7050):518\u201324.","journal-title":"Nature"},{"issue":"11","key":"2193_CR25","doi-asserted-by":"publisher","first-page":"3376","DOI":"10.1158\/0008-5472.CAN-15-2654","volume":"76","author":"M AlHossiny","year":"2016","unstructured":"AlHossiny M, Luo L, Frazier WR, Steiner N, Gusev Y, Kallakury B, Glasgow E, Creswell K, Madhavan S, Kumar R, et al. Ly6E\/K signaling to TGFbeta promotes breast cancer progression, immune escape, and drug resistance. Cancer Res. 2016;76(11):3376\u201386.","journal-title":"Cancer Res"},{"issue":"29","key":"2193_CR26","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1038\/onc.2009.126","volume":"28","author":"AB Dydensborg","year":"2009","unstructured":"Dydensborg AB, Rose AA, Wilson BJ, Grote D, Paquet M, Giguere V, Siegel PM, Bouchard M. GATA3 inhibits breast cancer growth and pulmonary breast cancer metastasis. Oncogene. 2009;28(29):2634\u201342.","journal-title":"Oncogene"},{"key":"2193_CR27","doi-asserted-by":"crossref","unstructured":"Yin D, Zhou T, Xia X, Han C, Liu Z, Li Q, Shu Y, Xu H. Novel insights into HBV-hepatocellular carcinoma at single-cell sequencing. 2023;2(4):e60.","DOI":"10.1002\/mog2.60"},{"issue":"1","key":"2193_CR28","doi-asserted-by":"publisher","first-page":"4867","DOI":"10.1038\/s41467-021-25189-z","volume":"12","author":"R Taftaf","year":"2021","unstructured":"Taftaf R, Liu X, Singh S, Jia Y, Dashzeveg NK, Hoffmann AD, El-Shennawy L, Ramos EK, Adorno-Cruz V, Schuster EJ, et al. ICAM1 initiates CTC cluster formation and trans-endothelial migration in lung metastasis of breast cancer. Nat Commun. 2021;12(1):4867.","journal-title":"Nat Commun"},{"issue":"6","key":"2193_CR29","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1158\/0008-5472.CAN-18-2207","volume":"79","author":"UG Lo","year":"2019","unstructured":"Lo UG, Pong RC, Yang D, Gandee L, Hernandez E, Dang A, Lin CJ, Santoyo J, Ma S, Sonavane R, et al. IFNgamma-Induced IFIT5 promotes epithelial-to-mesenchymal transition in prostate cancer via MiRNA processing. Cancer Res. 2019;79(6):1098\u2013112.","journal-title":"Cancer Res"},{"issue":"11","key":"2193_CR30","doi-asserted-by":"publisher","first-page":"e53391","DOI":"10.15252\/embr.202153391","volume":"22","author":"AJ Freeman","year":"2021","unstructured":"Freeman AJ, Vervoort SJ, Michie J, Ramsbottom KM, Silke J, Kearney CJ, Oliaro J. HOIP limits anti-tumor immunity by protecting against combined TNF and IFN-gamma-induced apoptosis. EMBO Rep. 2021;22(11):e53391.","journal-title":"EMBO Rep"},{"key":"2193_CR31","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.intimp.2017.06.016","volume":"50","author":"Z Guinn","year":"2017","unstructured":"Guinn Z, Brown DM, Petro TM. Activation of IRF3 contributes to IFN-gamma and ISG54 expression during the immune responses to B16F10 tumor growth. Int Immunopharmacol. 2017;50:121\u20139.","journal-title":"Int Immunopharmacol"},{"issue":"14","key":"2193_CR32","doi-asserted-by":"publisher","first-page":"3252","DOI":"10.1158\/1078-0432.CCR-15-0156","volume":"21","author":"J Asundi","year":"2015","unstructured":"Asundi J, Crocker L, Tremayne J, Chang P, Sakanaka C, Tanguay J, Spencer S, Chalasani S, Luis E, Gascoigne K, et al. An antibody-drug conjugate directed against lymphocyte antigen 6 Complex, locus E (LY6E) provides robust tumor killing in a wide range of solid tumor malignancies. Clin Cancer Res. 2015;21(14):3252\u201362.","journal-title":"Clin Cancer Res"},{"issue":"21","key":"2193_CR33","doi-asserted-by":"publisher","first-page":"5588","DOI":"10.1158\/1078-0432.CCR-20-1067","volume":"26","author":"SM Tolaney","year":"2020","unstructured":"Tolaney SM, Do KT, Eder JP, LoRusso PM, Weekes CD, Chandarlapaty S, Chang CW, Chen SC, Nazzal D, Schuth E, et al. A phase I study of DLYE5953A, an Anti-LY6E antibody covalently linked to monomethyl auristatin E, in patients with refractory solid tumors. Clin Cancer Res. 2020;26(21):5588\u201397.","journal-title":"Clin Cancer Res"},{"issue":"D1","key":"2193_CR34","doi-asserted-by":"publisher","first-page":"D729","DOI":"10.1093\/nar\/gky1094","volume":"47","author":"R Zheng","year":"2019","unstructured":"Zheng R, Wan C, Mei S, Qin Q, Wu Q, Sun H, Chen CH, Brown M, Zhang X, Meyer CA, et al. Cistrome data browser: expanded datasets and new tools for gene regulatory analysis. Nucleic Acids Res. 2019;47(D1):D729\u201335.","journal-title":"Nucleic Acids Res"},{"key":"2193_CR35","doi-asserted-by":"publisher","first-page":"688575","DOI":"10.3389\/fgene.2021.688575","volume":"12","author":"Q Jiang","year":"2021","unstructured":"Jiang Q, Zhang J, Li F, Ma X, Wu F, Miao J, Li Q, Wang X, Sun R, Yang Y, et al. POLR2A promotes the proliferation of gastric cancer cells by advancing the overall cell cycle progression. Front Genet. 2021;12:688575.","journal-title":"Front Genet"},{"issue":"15","key":"2193_CR36","doi-asserted-by":"publisher","first-page":"8239","DOI":"10.1093\/nar\/gkz532","volume":"47","author":"S Hou","year":"2019","unstructured":"Hou S, Qu D, Li Y, Zhu B, Liang D, Wei X, Tang W, Zhang Q, Hao J, Guo W, et al. XAB2 depletion induces intron retention in POLR2A to impair global transcription and promote cellular senescence. Nucleic Acids Res. 2019;47(15):8239\u201354.","journal-title":"Nucleic Acids Res"},{"key":"2193_CR37","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.cytogfr.2018.04.001","volume":"41","author":"P Rozman","year":"2018","unstructured":"Rozman P, Svajger U. The tolerogenic role of IFN-gamma. Cytokine Growth Factor Rev. 2018;41:40\u201353.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"1","key":"2193_CR38","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1002\/JLB.4MIR0420-619RR","volume":"108","author":"S Mezouar","year":"2020","unstructured":"Mezouar S, Mege JL. Changing the paradigm of IFN-gamma at the interface between innate and adaptive immunity: macrophage-derived IFN-gamma. J Leukoc Biol. 2020;108(1):419\u201326.","journal-title":"J Leukoc Biol"},{"issue":"5","key":"2193_CR39","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1093\/intimm\/dxae001","volume":"36","author":"F Ihara","year":"2024","unstructured":"Ihara F, Yamamoto M. The role of IFN-gamma-mediated host immune responses in monitoring and the elimination of toxoplasma gondii infection. Int Immunol. 2024;36(5):199\u2013210.","journal-title":"Int Immunol"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-025-02193-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13058-025-02193-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-025-02193-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T17:18:07Z","timestamp":1768843087000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13058-025-02193-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2193"],"URL":"https:\/\/doi.org\/10.1186\/s13058-025-02193-5","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,12]]},"assertion":[{"value":"17 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal studies were reviewed and approved by the Animal Ethics Committee of Xuzhou Medical University. Animal experiment approval number: 202208S001. Registry and the Registration No. of the Study\/Trial: Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14"}}